Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

Bangladeshi mystic fights demons with psychiatry
15 September 2022
Experimental test promises to predict side-effects and cancer’s return in patients treated with immunotherapy
15 September 2022

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

Drugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used to treat advanced prostate cancer for more than a decade. While successful in most cases, these drugs can eventually stop working, but there is a limited understanding about how this change occurs.

Comments are closed.